• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CVS Pharmacy® introduces enhanced flu testing and treatment offerings

    2/27/25 9:45:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CVS alert in real time by email

    As flu cases continue to remain high, select CVS pharmacies across 37 states launch combo test for Flu A, Flu B and COVID-19

    Pharmacists can also prescribe flu treatment for eligible patients in 13 states with positive test results helping ensure timely access to care

    WOONSOCKET, R.I., Feb. 27, 2025 /PRNewswire/ -- With flu cases continuing to remain high in communities across the U.S., CVS Health® (NYSE:CVS) today announced that CVS Pharmacy® has enhanced its flu testing and treatment capabilities at roughly 1,600 locations in select states.



    Participating CVS Pharmacy locations in 37 states have begun using a new 3-in-1 combo test when patients present with flu-like symptoms, allowing them to be tested for Influenza A, Influenza B, and COVID-19 with one swab.



    In addition, the company has streamlined scheduling for test and treat appointments through its digital scheduler on CVS.com and the CVS Health app. In states that allow pharmacists to both test and treat for COVID-19 and flu, patients may now be tested and assessed by a CVS pharmacist for antiviral treatment in one appointment. Participating states include California, Colorado, Idaho, Illinois, Michigan, Minnesota, Montana, Nebraska, South Dakota, Tennessee, Washington, Wisconsin, and Wyoming.

    CVS pharmacist consulting with a patient.

    "Timely access to care and treatment is critical with illnesses like influenza and COVID-19," said Jinali Desai, PharmD, MBA, MPH, Vice President, Pharmacy Health Services for CVS Health. "CVS Pharmacy's array of testing and treatment options allows us to be with our patients every step of the way. From immunizations to symptom evaluation to prescribing medications for those who are eligible, our trusted pharmacists offer convenient and accessible care when patients need us most."

    A pharmacy-administered flu and COVID-19 test costs $29.99. The pharmacist assessment will cost $45, regardless of whether medication is prescribed. Patients may use HSA or FSA funds to cover the assessment fee. Any cost or copay for a prescribed medication is dependent on the patient's prescription insurance coverage.

    At-Home Test Options

    CVS Pharmacy offers several at-home flu and COVID-19 test options as well, enabling patients to test for these illnesses in the comfort of their own home. Three different combo tests, priced at $12.99 and $24.99, are available for purchase on CVS.com and at the company's retail stores nationwide.  

    If a patient tests positive at-home and is seeking treatment, they can request a pharmacist evaluation via CVS.com or the CVS Health app and, if clinically appropriate, may be prescribed a medication. Pharmacist evaluations are available during weekend and evening hours. 

    "Through our clinical pharmacy care offerings and extensive selection over-the-counter wellness products, we can help people with all of their wellness needs," added Desai.  

    To make it even more convenient, CVS Pharmacy offers several delivery options for customers and patients with eligible prescriptions, including same-day delivery and 1-2-day delivery.

    Help prevent illness with immunizations

    Immunization is the most effective way to help prevent the flu. Both the flu vaccine and updated 2024-2025 COVID-19 vaccine are still available at CVS Pharmacy® and MinuteClinic® locations nationwide. MinuteClinic also offers sick symptom visits during which patients can be tested for flu, COVID-19, and strep throat, if eligible. Walk-ins are accepted at CVS Pharmacy and the company's digital vaccine scheduler reflects available appointments at CVS Pharmacy and MinuteClinic.

    Patients ages six months and older should receive the updated flu and COVID-19 vaccine to restore and enhance protection against the most prevalent virus variants currently circulating. While the ideal time to receive a flu shot is before the winter months, it's not too late to get an updated dose. 



    In addition, people age 65 and older who received the updated COVID-19 vaccine in the fall of 2024 can receive a second dose six months after the first. People who are moderately or severely immunocompromised are eligible for a second dose as well. This means that patients who received an updated COVID-19 in September or October 2024 would be eligible for another dose in March or April 2025. 

    Video and photo assets from CVS Pharmacy and MinuteClinic are available here.

    About CVS Health

    CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

    Media contact

    Amy Thibault

    401-318-2865

    [email protected]

    CVS Health (PRNewsFoto/CVS Health)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-pharmacy-introduces-enhanced-flu-testing-and-treatment-offerings-302387520.html

    SOURCE CVS Health

    Get the next $CVS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CVS

    DatePrice TargetRatingAnalyst
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    1/30/2025Hold → Buy
    Edward Jones
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    11/18/2024$60.00 → $66.00Equal Weight → Overweight
    Wells Fargo
    10/10/2024$63.00 → $82.00Equal Weight → Overweight
    Barclays
    10/4/2024$59.00 → $85.00Hold → Buy
    TD Cowen
    5/30/2024$61.00Neutral
    Robert W. Baird
    More analyst ratings

    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CVS Health upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded CVS Health from Market Perform to Outperform and set a new price target of $75.00 from $55.00 previously

      2/13/25 7:04:02 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health upgraded by Cantor Fitzgerald

      Cantor Fitzgerald upgraded CVS Health from Neutral to Overweight

      2/12/25 2:18:18 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health upgraded by Edward Jones

      Edward Jones upgraded CVS Health from Hold to Buy

      1/30/25 7:09:02 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    SEC Filings

    See more
    • SEC Form 13F-HR filed by CVS Health Corporation

      13F-HR - CVS HEALTH Corp (0000064803) (Filer)

      5/2/25 4:08:15 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by CVS Health Corporation

      10-Q - CVS HEALTH Corp (0000064803) (Filer)

      5/1/25 6:35:46 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CVS HEALTH Corp (0000064803) (Filer)

      5/1/25 6:32:09 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Financials

    Live finance-specific insights

    See more
    • AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

      AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.) Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary with subsidiaries of A

      5/8/25 4:47:00 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

      First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior yearGAAP diluted EPS of $1.41 and Adjusted EPS of $2.25Generated cash flow from operations of $4.6 billionOperational Highlights CVS Health to exit the individual exchange businessAetna® introduces new solutions to ease the patient and provider experienceCVS Caremark® makes formulary update to improve access to GLP-1 drugs2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $4.23 to $4.43 from $4.58 to $4.83Raised Adjusted EPS guidance range to $6.00 to $6.20 from $5.75 to $6.00Raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 bil

      5/1/25 6:30:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health to hold first quarter 2025 earnings conference call

      WOONSOCKET, R.I., April 3, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Thursday, May 1st, 2025, at 8:00 a.m. ET to discuss first quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2024, th

      4/3/25 9:00:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      2/19/25 12:35:35 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Ludwig Edward J bought $53,879 worth of shares (1,000 units at $53.88), increasing direct ownership by 5% to 21,630 units (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      5/2/24 4:31:44 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Mahoney Michael F bought $500,294 worth of shares (9,181 units at $54.49), increasing direct ownership by 5,246% to 9,356 units (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      5/2/24 4:30:49 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by CVS Health Corporation

      SC 13G - CVS HEALTH Corp (0000064803) (Subject)

      11/13/24 1:00:57 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

      SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

      2/13/24 5:02:40 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

      SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

      2/9/23 11:16:32 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Robbins Larry sold $253,695,413 worth of shares (3,750,000 units at $67.65) (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      5/6/25 4:15:27 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • EVP and Group President Shah Prem S covered exercise/tax liability with 1,308 shares and was granted 26,478 shares, increasing direct ownership by 20% to 58,166 units (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      4/3/25 4:43:05 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • EVP and President, Aetna Nelson Steven H was granted 21,329 shares (SEC Form 4)

      4 - CVS HEALTH Corp (0000064803) (Issuer)

      4/3/25 4:29:13 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

      AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.) Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary with subsidiaries of A

      5/8/25 4:47:00 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Glenview Capital Issues Statement on CVS Health

      NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE:CVS). Since our purchases in May 2024, CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company.  Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan: Board Refreshment – The Board welcomed four new Directors including Larry Robbins, Glenview's CEO, and recently appointed a strong Lead Independent Director.  The entire Board is operating cooperat

      5/6/25 4:15:00 PM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

      First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior yearGAAP diluted EPS of $1.41 and Adjusted EPS of $2.25Generated cash flow from operations of $4.6 billionOperational Highlights CVS Health to exit the individual exchange businessAetna® introduces new solutions to ease the patient and provider experienceCVS Caremark® makes formulary update to improve access to GLP-1 drugs2025 Full-Year Guidance Revised GAAP diluted EPS guidance range to $4.23 to $4.43 from $4.58 to $4.83Raised Adjusted EPS guidance range to $6.00 to $6.20 from $5.75 to $6.00Raised cash flow from operations guidance to approximately $7.0 billion from approximately $6.5 bil

      5/1/25 6:30:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $CVS
    Leadership Updates

    Live Leadership Updates

    See more
    • CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

      WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

      4/8/25 6:30:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health Foundation helps address barriers to care and provides resources for individuals with chronic health conditions in Hartford

      Foundation announces $2 million in new Health Zones funding to support at-risk populations WOONSOCKET, R.I., March 6, 2025 /PRNewswire/ -- The CVS Health® Foundation today announced $2 million in new Health Zones funding to support the Hispanic Health Council's Family Wellness Center and its agency partners, all located in Hartford, Connecticut. This funding will help address critical gaps in the health care and social system for individuals with chronic health conditions by increasing access to comprehensive health care services and resources. "A variety of interconnected fac

      3/6/25 8:30:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CVS Health announces Pharmacy and Consumer Wellness leadership appointments

      WOONSOCKET, R.I., Dec. 3, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group president, CVS Health. In addition, the company announced the appointment of Lucille Accetta, RPh, MPH, MBA as chief pharmacy officer, also reporting to Shah. Both appointments are effective immediately. As president, Pharmacy and Consumer Wellness, Shankman will oversee the front store and retail pharmacy businesses across the company's more than 9,000 CVS Pharmacy locations. In his new

      12/3/24 7:00:00 AM ET
      $CVS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples